Jeffrey G. Lamothe insider trades

Open-market stock purchases and sales by Jeffrey G. Lamothe, President and CEO at Aptevo Therapeutics Inc, from SEC Form 4 filings since Aug 3, 2016.

Recent trades

DateStockTradeValue
Aug 6, 2026APVO Aptevo Therapeutics IncBought (not open market)—
Aug 6, 2026APVO Aptevo Therapeutics IncBought (not open market)—

Companies traded

  • APVO Aptevo Therapeutics Inc: other filings, last Aug 6, 2026

Get free alerts when Jeffrey G. Lamothe files a new trade →